Filter posts

Fighting Ebola with Tobacco

Years in the making, the Ebola virus has recently erupted into a full blown health …

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, …

Decoding Genes to find Breast Cancer

Today, August 7, 2014, researchers at the University Medical Center Utrecht announced that they have identified a …

New study shows hepatitis C burden may ease in future

Anew study published in the Annals of Internal Medicine projects that the prevalence of hepatitis …

NYT Columnist: Insurance Industry “Looking at the Costs of Sovaldi in the Wrong Way”

Margot Sanger-Katz’s article on a new drug that treats hepatitis C notes that despite the …

Treating Hepatitis C: Too Costly Not to Act

Today, The Hill published an op-ed – Treating hepatitis C: Too costly not to act …

New Report: Innovation in Hepatitis C Treatment

Today, the California Healthcare Institute released a report on the public health impact of Hepatitis …

BioCentury TV This Week: 340B Drug Discount Program Needs More Oversight

BIO’s Laurel Todd shared concerns that the 340B program has departed significantly from its original …

Beggar-Thy-Neighbor Medicine: Wall Street Journal Op-Ed

In an editorial about specialty drug prices, the Wall Street Journal writes: “To understand how …

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology …